Tag: Certificate

Titan Pharmaceuticals’ Stockholders Approve Proposal To Amend Its Certificate Of Incorporation

[email protected]_84 business proposals

SOUTH SAN FRANCISCO, Calif., Sept. 18, 2020 /PRNewswire/ — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced that, at today’s special meeting, its stockholders approved the proposal to amend Titan’s certificate of incorporation to increase the number of authorized shares of common stock from 125 million to 225 million (the “Amendment”).

The voting results are available in our Current Report on Form 8-K filed with the SEC today.

“On behalf of the Board and management team, I would like to thank our stockholders for their continued support and we look forward to updating you on our progress,” said Titan’s Executive Chairman, Dr. Marc Rubin.

About Titan Pharmaceuticals

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), based in South San Francisco, CA, is a commercial stage company developing proprietary therapeutics with its ProNeura® long-term, continuous drug delivery technology. The Company’s lead product is Probuphine® (buprenorphine) implant, a novel

… Read More
Read More

Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation

[email protected]_84 business proposals

SOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 /PRNewswire/ — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today provided an update on the upcoming special meeting of stockholders (the “Meeting”) in response to recent stockholder inquiries regarding the number of meeting adjournments. The sole purpose of the Meeting is to seek approval of a proposal to amend Titan’s certificate of incorporation to increase the number of authorized shares of common stock.

Without approval of the share increase, the several strategic alternatives management has been exploring with the Company’s bankers will not be possible. The failure to obtain stockholder approval will almost certainly result in the cessation of Titan’s operations and likely a total loss of value to stockholders, given the pledge of all of the Company’s assets as security for its outstanding debt.

The goal of Titan’s Board of Directors is to enable as many stockholders as possible

… Read More
Read More